ReadyGo Diagnostics
Private Company
Funding information not available
Overview
ReadyGo Diagnostics is an innovator in decentralized diagnostics, creating integrated platforms that turn a biological sample into the start of a test. Its proprietary active materials simultaneously collect, lyse, preserve, and rehydrate dry reagents, eliminating complex lab prep and enabling use in point-of-care, at-home, or field settings. The company targets the growing demand for self-testing and remote health monitoring across human health, veterinary, and agricultural sectors. By merging multiple workflow steps into one intelligent material, ReadyGo seeks to make diagnostics faster, more accessible, and less error-prone.
Technology Platform
Proprietary engineered material matrices that actively collect, lyse, stabilize, and store dry reagents for biological samples (saliva, blood, urine). The platform integrates sample preparation and test initiation into a single step upon sample addition.
Opportunities
Risk Factors
Competitive Landscape
ReadyGo competes in the decentralized diagnostics space against large diagnostic companies (e.g., Abbott, Roche) with integrated systems and numerous startups focusing on point-of-care molecular or rapid testing. Its differentiation hinges on its proprietary active material that combines several workflow steps, aiming for greater simplicity and lower cost than conventional approaches.